WallStSmart

Clover Health Investments Corp (CLOV)vsUnitedHealth Group Incorporated (UNH)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

UnitedHealth Group Incorporated generates 20264% more annual revenue ($450.13B vs $2.21B). UNH leads profitability with a 3.1% profit margin vs -2.6%. UNH earns a higher WallStSmart Score of 62/100 (C+).

CLOV

Avoid

34

out of 100

Grade: F

Growth: 8.0Profit: 2.5Value: 6.7Quality: 3.8
Piotroski: 2/9Altman Z: -1.87

UNH

Buy

62

out of 100

Grade: C+

Growth: 7.3Profit: 5.5Value: 4.0Quality: 6.0
Piotroski: 4/9Altman Z: 2.28
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CLOVUndervalued (+69.1%)

Margin of Safety

+69.1%

Fair Value

$6.63

Current Price

$4.23

$2.40 discount

UndervaluedFair: $6.63Overvalued
UNHSignificantly Overvalued (-30.5%)

Margin of Safety

-30.5%

Fair Value

$322.25

Current Price

$420.57

$98.32 premium

UndervaluedFair: $322.25Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CLOV1 strengths · Avg: 10.0/10
Revenue GrowthGrowth
62.0%10/10

Revenue surging 62.0% year-over-year

UNH3 strengths · Avg: 10.0/10
Market CapQuality
$391.69B10/10

Mega-cap, among the largest globally

EPS GrowthGrowth
61.5%10/10

Earnings expanding 61.5% YoY

Free Cash FlowQuality
$10.25B10/10

Generating 10.3B in free cash flow

Areas to Watch

CLOV4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Operating MarginProfitability
3.6%3/10

Operating margin of 3.6%

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Return on EquityProfitability
-16.8%2/10

ROE of -16.8% — below average capital efficiency

UNH3 concerns · Avg: 3.7/10
P/E RatioValuation
32.9x4/10

Premium valuation, high expectations priced in

Revenue GrowthGrowth
0.4%4/10

0.4% revenue growth

Profit MarginProfitability
3.1%3/10

3.1% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : CLOV

The strongest argument for CLOV centers on Revenue Growth. Revenue growth of 62.0% demonstrates continued momentum.

Bull Case : UNH

The strongest argument for UNH centers on Market Cap, EPS Growth, Free Cash Flow. PEG of 1.43 suggests the stock is reasonably priced for its growth.

Bear Case : CLOV

The primary concerns for CLOV are EPS Growth, Operating Margin, Piotroski F-Score.

Bear Case : UNH

The primary concerns for UNH are P/E Ratio, Revenue Growth, Profit Margin. Thin 3.1% margins leave little buffer for downturns.

Key Dynamics to Monitor

CLOV profiles as a hypergrowth stock while UNH is a value play — different risk/reward profiles.

CLOV carries more volatility with a beta of 2.42 — expect wider price swings.

CLOV is growing revenue faster at 62.0% — sustainability is the question.

UNH generates stronger free cash flow (10.3B), providing more financial flexibility.

Bottom Line

UNH scores higher overall (62/100 vs 34/100). CLOV offers better value entry with a 69.1% margin of safety. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Clover Health Investments Corp

HEALTHCARE · HEALTHCARE PLANS · USA

Clover Health Investments, Corp. The company is headquartered in Franklin, Tennessee.

Visit Website →

UnitedHealth Group Incorporated

HEALTHCARE · HEALTHCARE PLANS · USA

UnitedHealth Group Incorporated is an American for-profit multinational managed healthcare and insurance company based in Minnetonka, Minnesota. It offers health care products and insurance services. In 2020, it was the second-largest healthcare company (behind CVS Health) by revenue with $257.1 billion, and the largest insurance company by net premiums. UnitedHealthcare revenues comprise 80% of the Group's overall revenue.

Visit Website →

Want to dig deeper into these stocks?